Discontinuation report RANITIDINE
| Report ID | 120743 |
| Drug Identification Number | 00740748 |
| Brand name | RANITIDINE |
| Common or Proper name | RANITIDINE -150 |
| Company Name | PRO DOC LIMITEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60, 500 |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | Regulatory issues- Enjeux réglementaires We are looking to re-introduce into the market |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-04-01 | French | Compare |
| v5 | 2021-04-01 | English | Compare |
| v4 | 2020-07-22 | French | Compare |
| v3 | 2020-07-22 | English | Compare |
| v2 | 2020-07-22 | French | Compare |
| v1 | 2020-07-22 | English | Compare |
Showing 1 to 6 of 6